All-In with Chamath, Jason, Sacks & Friedberg cover image

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

All-In with Chamath, Jason, Sacks & Friedberg

00:00

China, Patent Strategy, and 'Patent Hacking'

Dave explains first-to-file impacts, China's reverse-engineering tactics, and how that pressures biotech valuations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app